The most common cause of death of septic surgical patients is now the multiple system organ failure syndrome (MSOF). Although renal failure and respiratory failure can be counteracted by external support systems, hepatic failure cannot. One hypothesis for the possible pathogenesis of hepatic failure in septic surgical patients deserves further study; The Kupffer cells, specialized macrophages within the liver sinusoids, receive and normally clear the bloodstream of circulating septic stimuli. In the process they become stimulated, which may lead in turn, to the production of mediators that alter the function of contiguous hepatocytes. We have obtained a significant body of preliminary data supporting this hypothesis. These data derive from direct co-cultivation of Kupffer cells (or macrophages) and hepatocytes. Septic stimuli (lipopolysaccharide or killed bacteria) added to co-culture resulted in a significant depression in protein synthesis of the hepatocytes. In contrast, co-culture in the absence of septic stimuli markedly enhanced hepatocyte protein synthesis. The same septic stimuli had no direct effect on protein synthesis of hepatocytes cultured alone (without Kupffer cells or macrophages). Subsequent experiments have indicated that Kupffer cells may modulate hepatocyte protein synthesis via soluble (? protein) monokines. The present grant proposal is designed: 1) to characterize the role of hepatocyte:Kupffer cell interactions in alterations of hepatocyte function in surgical sepsis, 2) to determine the mechanism(s) or mediator(s) through which Kupffer cells/macrophages alter hepatocyte function. Though the Kupffer cell mediated effects may represent a physiologic modulation of hepatocyte function, a continuum between physiologic alterations and pathologic injury may exist.

Agency
National Institute of Health (NIH)
Institute
National Institute of General Medical Sciences (NIGMS)
Type
Research Project (R01)
Project #
1R01GM037753-01
Application #
3293411
Study Section
Surgery, Anesthesiology and Trauma Study Section (SAT)
Project Start
1986-12-01
Project End
1987-11-30
Budget Start
1986-12-01
Budget End
1987-11-30
Support Year
1
Fiscal Year
1987
Total Cost
Indirect Cost
Name
University of Minnesota Twin Cities
Department
Type
Schools of Medicine
DUNS #
168559177
City
Minneapolis
State
MN
Country
United States
Zip Code
55455
Loughran, P A; Stolz, D B; Vodovotz, Y et al. (2005) Monomeric inducible nitric oxide synthase localizes to peroxisomes in hepatocytes. Proc Natl Acad Sci U S A 102:13837-42
Mahidhara, Raja S; Hoffman, Rosemary A; Huang, Sulan et al. (2003) Nitric oxide-mediated inhibition of caspase-dependent T lymphocyte proliferation. J Leukoc Biol 74:403-11
Stolz, Donna Beer; Zamora, Ruben; Vodovotz, Yoram et al. (2002) Peroxisomal localization of inducible nitric oxide synthase in hepatocytes. Hepatology 36:81-93
Zamora, R; Vodovotz, Y; Alarcon, L et al. (2001) Nitric oxide from the inducible nitric oxide synthase (iNOS) increases the expression of cytochrome P450 2E1 in iNOS-null hepatocytes in the absence of inflammatory stimuli. Arch Biochem Biophys 390:287-94
Kim, Y M; Chung, H T; Simmons, R L et al. (2000) Cellular non-heme iron content is a determinant of nitric oxide-mediated apoptosis, necrosis, and caspase inhibition. J Biol Chem 275:10954-61
Villavicencio, R T; Liu, S; Kibbe, M R et al. (2000) Induced nitric oxide inhibits IL-6-induced stat3 activation and type II acute phase mRNA expression. Shock 13:441-5
Li, J; Billiar, T R (2000) The role of nitric oxide in apoptosis. Semin Perinatol 24:46-50
Li, J; Billiar, T R (1999) The anti-apoptotic actions of nitric oxide in hepatocytes. Cell Death Differ 6:952-5
Taylor, B S; Shao, L; Gambotto, A et al. (1999) Inhibition of cytokine-induced nitric oxide synthase expression by gene transfer of adenoviral I kappa B alpha. Surgery 126:142-7
Li, J; Billiar, T R (1999) Nitric Oxide. IV. Determinants of nitric oxide protection and toxicity in liver. Am J Physiol 276:G1069-73

Showing the most recent 10 out of 116 publications